These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 9516895)

  • 1. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").
    Newnham DM; Lipworth BJ
    Thorax; 1994 Aug; 49(8):762-70. PubMed ID: 8091320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.
    Clark DJ; Lipworth BJ
    Thorax; 1996 Oct; 51(10):981-4. PubMed ID: 8977596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.
    Rodrigo C; Rodrigo G
    Am J Emerg Med; 1998 Nov; 16(7):637-42. PubMed ID: 9827736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
    Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
    Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):160-3. PubMed ID: 9491830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor regulation and function in female asthmatic patients receiving the oral combined contraceptive pill.
    Tan KS; McFarlane LC; Lipworth BJ
    Chest; 1998 Feb; 113(2):278-82. PubMed ID: 9498939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery in asthma: a comparison of spacers with a jet nebuliser.
    Gibson PG; Wlodarczyk JH; Borgas T
    Aust N Z J Med; 1995 Aug; 25(4):324-9. PubMed ID: 8540873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma.
    Razzouk H; dos Santos L; Giudicelli J; Queirós M; de Lurdes Chieira M; Castro A; Ramos C; Lindbladh C
    Int J Pharm; 1999 Apr; 180(2):169-75. PubMed ID: 10370187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma.
    Freeman W; Packe GE; Cayton RM
    Thorax; 1989 Nov; 44(11):942-7. PubMed ID: 2595636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1988 Nov; 26(5):527-33. PubMed ID: 2849969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask.
    Parkes SN; Bersten AD
    Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.
    Delvaux M; Henket M; Lau L; Kange P; Bartsch P; Djukanovic R; Louis R
    Thorax; 2004 Feb; 59(2):111-5. PubMed ID: 14760148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.